Atorvastatin is contraindicated during pregnancy because of potential danger to the fetus. To notify prescriber immediately if pregnancy occurs or is suspected.
Instructed in new medication Synthroid and in S/E such as nervousness, insomnia, tremor, headache, fever, tachycardia, palpitations, arrhythmias, angina pectoris, cardiac arrest, diarrhea, vomiting, menstrual irregularities, weight loss, allergic skin reactions, diaphoresis or heat intolerance.
Instructed in new medication Metaproterenol sulfate, to manage bronchial asthma. In addition, warned of possible S/E such as vertigo, headache, nervousness, dry and irritated throat, vomiting, nausea, dry mouth, etc.
Instructed in vitamin B12, ordered to management anemia and in S/E such as itching, urticaria, pain or burning in injection sites, transient diarrhea, transitory exanthema, etc.
Instructed in Vitamin B1 and in S/E such as weakness, restlessness, nauseas, uriticaria, pruritus, tenderness, and ?induration after IM administration. .
Instructed in Novolin 70/30 to manage diabetes. In addition, warned of possible S/E such as abdominal pain, diarrhea, and flatulence. Adverse effects usually occur during the first few week of therapy. Generally, these effects diminish over time.
Instructed in new medication Levaquin to manage infection. In addition, warned of possible S/E such as headache, insomnia, dizziness, encephalopathy, chest pain, palpitations, vasodilation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, vaginitis, eosinophilia, hypoglycemia, back pain, tendon rupture, rash, pruritus, hypersensitivity reactions, etc. Instructed to take drug as prescribed, even if signs and symptoms disappear. Take drug with plenty of fluids and avoid antacids, sucralfate, and products containing iron or zinc for at least 2 hours before and after each dose. Avoid excessive sunlight, use sun block, and wear protective clothing when outdoors. Stop drug usage and notify prescriber if rash or other S/S of hypersensitivity develop. Notify prescriber if patient experiences pain or inflammation. Tendon rupture can occur with drug. Instructed to Diabetic patient to monitor glucose level and notify prescriber if a hypoglycemia reaction occurs. Notify prescriber if loose stools or diarrhea occurs.
Instructed in new medication Bactroban to manage wound care. In addition, warned of possible S/E such as headache, rhinitis, pharyngitis, burning or stinging with intranasal use, taste perversion, upper respiratory tract congestion, cough with intranasal use, burning pruritis, stinging, rash, pain, and erythema with topical use. Instructed to notify prescriber immediately if no improvement occurs in 3 to 5 days or if condition worsens. Advised not to use other nasal products with Bactroban. Warned patient about local adverse reactions related to drug use. Advised not to use cosmetics or other skin products on treated area.
Instructed in new medication Albuterol to prevent or treat bronchospasm in patients with reversible obstructive airway disease. In addition, warned of possible S/E such as tremor, nervousness, dizziness, insomnia, headache, hyperactivity, weakness, CNS stimulation, malaise, tachycardia, palpitations, hypertension, dry and irritated nose and throat (with inhaled form), nasal congestion, epistaxis, hoarseness, heartburn, nausea, vomiting, anorexia, bad taste in mouth, increased appetite, hypokalemia, muscle cramps, bronchospasm, cough, wheezing, dyspnea, bronchitis, increased sputum or hypersensitivity reactions. Warned patient about possibility of paradoxical bronchospasm. If this occurs, discontinue drug immediately. If more than one inhalation is ordered, instructed to wait at least 2 minutes before repeating procedure. Use of an aero chamber may improve drug delivery to the lungs. If steroid inhaler used, advised to use the bronchodilator first and then advised to wait about 5 minutes before using the steroid. This allows the bronchodilator to open the air passages for maximum effectiveness. Advised to remove canister and wash inhaler with warm, soapy water at least once a week.
Instructed to perform oral inhalation correctly: Shake the inhaler. Clear nasal passages and throat. Breathe out, expelling as much air from lungs as possible. Place mouthpiece well into mouth as dose from inhaler is released and inhale deeply. Hold breath for several seconds, remove mouthpiece and exhale slowly. Or, inhaler may be held about 1 inch (two finger widths) from open mouth; inhale while dose is released.